Market Value111,460,000
Total Holdings63
File Date2017-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BMY / Bristol-Myers Squibb Company
BMY / Bristol-Myers Squibb Company Call
ALKS / Alkermes plc
AGIO / Agios Pharmaceuticals, Inc.
TSRO / TESARO, Inc.
MRK / Merck & Co., Inc.
MYGN / Myriad Genetics, Inc.
CLVS / Clovis Oncology Inc
SIOX / Sio Gene Therapies Inc.
IOVA / Iovance Biotherapeutics, Inc.
PCRX / Pacira BioSciences, Inc.
BIVV / Bioverativ Inc.
LLY / Eli Lilly and Company Call
SNR / New Senior Investment Group Inc
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
PGNX / Progenics Pharmaceuticals, Inc.
LOXO / Loxo Oncology, Inc.
CFRX / ContraFect Corp
SCYX / SCYNEXIS, Inc.
PRTK / Paratek Pharmaceuticals Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
AVXS / AveXis, Inc.
MDCO / Medicines Company
BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology
BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology Put
US0153511094 / Alexion Pharmaceuticals, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc. Call
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
451731103 / Ignyta, Inc.
JUNO / Juno Therapeutics, Inc.
PGEN / Precigen, Inc.
AKBA / Akebia Therapeutics, Inc.
KPTI / Karyopharm Therapeutics Inc.
CRL / Charles River Laboratories International, Inc.
HRTX / Heron Therapeutics, Inc.
ADMS / Adamas Pharmaceuticals Inc
KITE / Kite Pharma, Inc.
GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
PFE / Pfizer Inc.
NBIX / Neurocrine Biosciences, Inc.
IQV / IQVIA Holdings Inc.
UTHR / United Therapeutics Corporation
REPH / Societal CDMO Inc
GSK / GSK plc - Depositary Receipt (Common Stock)
BMRN / BioMarin Pharmaceutical Inc.
GILD / Gilead Sciences, Inc.
GILD / Gilead Sciences, Inc. Call
TECH / Bio-Techne Corporation
CKPT / Checkpoint Therapeutics, Inc.
CELG / Celgene Corp.
REGN / Regeneron Pharmaceuticals, Inc.
AMGN / Amgen Inc.
AXSM / Axsome Therapeutics, Inc.
ILMN / Illumina, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
BIIB / Biogen Inc.
LGND / Ligand Pharmaceuticals Incorporated
SGEN / Seagen Inc
ACAD / ACADIA Pharmaceuticals Inc.
LABU / Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
QGEN / Qiagen N.V.
MTD / Mettler-Toledo International Inc.
ICPT / Intercept Pharmaceuticals Inc
IBB / iShares Trust - iShares Biotechnology ETF
IBB / iShares Trust - iShares Biotechnology ETF Put
VRTX / Vertex Pharmaceuticals Incorporated
RARE / Ultragenyx Pharmaceutical Inc.
IONS / Ionis Pharmaceuticals, Inc.
INCY / Incyte Corporation
NKTR / Nektar Therapeutics